US Broker Ratings

Premier, Inc. (PINC) Stock Report: Navigating Healthcare with a 2.97% Dividend Yield

Premier, Inc. (NASDAQ: PINC) operates at the intersection of technology and healthcare, offering a suite of services that include data analytics, supply chain solutions, and software-as-a-service..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: A 27.96% Upside Potential Awaits Investors

Supernus Pharmaceuticals, Inc. (SUPN) stands out as a promising opportunity for investors seeking growth in the healthcare sector. With a market capitalization of $2.71 billion, this..

Harmony Biosciences Holdings, Inc. (HRMY) Stock Analysis: A Look at its Promising 18.66% Upside Potential

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) stands as a compelling player in the biotechnology industry, offering investors significant growth potential. This commercial-stage pharmaceutical company, with a..

Recursion Pharmaceuticals, Inc. (RXRX) Investor Outlook: Analyzing the 50.79% Potential Upside

Recursion Pharmaceuticals, Inc. (RXRX) stands as a beacon in the biotechnology industry, offering a compelling investment narrative for those with an eye on innovative healthcare solutions...

PROCEPT BioRobotics (PRCT) Stock Analysis: Eyeing a 41% Upside with Robust Revenue Growth

PROCEPT BioRobotics Corporation (NASDAQ: PRCT), a cutting-edge healthcare player specializing in medical devices, has positioned itself as a transformative force in the field of surgical robotics...

Envista Holdings Corporation (NVST) Stock Analysis: Understanding the 1.12% Potential Upside

Envista Holdings Corporation (NYSE: NVST), a key player in the healthcare sector, particularly in the medical instruments and supplies industry, offers a diverse range of dental..

Ardent Health, Inc. (ARDT) Stock Report: Analyst Ratings Hint at 56.84% Upside Potential

Ardent Health, Inc. (ARDT), a key player in the healthcare sector with a focus on medical care facilities, is attracting attention from investors due to its..

Apogee Therapeutics, Inc. (APGE): Investor Outlook on a Promising Biotech with 26% Upside Potential

Apogee Therapeutics, Inc. (NASDAQ: APGE), a burgeoning name in the biotechnology sector, is gaining momentum with analysts and investors alike. Headquartered in Waltham, Massachusetts, the company..

Metsera, Inc. (MTSR) Stock Analysis: Navigating a -19.15% Potential Downside in the Biotech Sector

Metsera, Inc. (MTSR), a promising player in the biotechnology sector, has garnered attention for its innovative approach to tackling obesity and related diseases. Operating as a..

Zai Lab Limited (ZLAB) Stock Analysis: Unpacking a 185% Potential Upside in Biotech

Investors with a keen eye on the biotechnology sector may find Zai Lab Limited (NASDAQ: ZLAB) an intriguing opportunity. The Shanghai-based biopharmaceutical company, with a market..

Addus HomeCare Corporation (ADUS): Investor Outlook Reveals 22.89% Potential Upside

Addus HomeCare Corporation (NASDAQ: ADUS) is a key player in the healthcare sector, specifically in the medical care facilities industry. With a market capitalization of $2.13..

ICU Medical, Inc. (ICUI)

⚠️ No article content returned.

..

Vericel Corporation (VCEL) Stock Analysis: Uncovering a 52.68% Potential Upside for Investors

Vericel Corporation (NASDAQ: VCEL) stands as a formidable player in the healthcare sector, specifically within the biotechnology industry. With a market capitalization of $1.85 billion, Vericel..

LifeStance Health Group, Inc. (LFST): Investor Outlook and Growth Potential with a 23.64% Upside

LifeStance Health Group, Inc. (LFST), a prominent player in the healthcare sector, specializes in providing outpatient mental health services across the United States. With a market..

GeneDx Holdings Corp. (WGS) Stock Analysis: Unlocking a 9.41% Potential Upside with Strong Analyst Support

GeneDx Holdings Corp. (WGS), a prominent player in the healthcare sector specializing in diagnostics and research, is capturing the attention of investors with a compelling growth..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: High Market Cap and Analyst Optimism in the Biotech Arena

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a notable player in the biotechnology sector, offers an intriguing proposition for investors with a keen eye on the healthcare landscape...

CRISPR Therapeutics AG (CRSP) Investor Outlook: Uncovering a 44% Potential Upside in Gene Editing Pioneer

For investors keeping a close eye on the biotechnology sector, CRISPR Therapeutics AG (NASDAQ: CRSP) presents a compelling opportunity, particularly given its groundbreaking work in gene..

Organon & Co. (OGN) Stock Analysis: Unveiling a 33% Potential Upside Amidst Analyst Divergence

As Organon & Co. (NYSE: OGN) navigates the ever-evolving healthcare landscape, investors are drawn to the stock’s potential upside of 33.29%, as highlighted by the average..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: High Growth Potential with 34.95% ROE in the Biotech Sector

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) stands as a noteworthy player in the biotechnology sector, particularly for investors with an eye on innovative therapies for central nervous..

Arrowhead Pharmaceuticals (ARWR): Investor Outlook on a Biotech Gem with a $9.46 Billion Market Cap

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) stands as a noteworthy contender in the biotechnology sector, given its robust market capitalization of $9.46 billion. This California-based company is..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds